within Pharmacolibrary.Drugs.ATC.S;

model S01EB58
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.05,
    Cl             = 0.016666666666666666,
    adminDuration  = 600,
    adminMass      = 0.005,
    adminCount     = 1,
    Vd             = 0.0001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Aceclidine is a parasympathomimetic miotic agent primarily used in ophthalmology for the treatment of glaucoma and other ocular conditions to reduce intraocular pressure. It acts as a muscarinic receptor agonist. Currently, aceclidine is not widely used and is not approved in many countries.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic parameters for aceclidine in combination products with ATC code S01EB58 were identified in the literature. The following PK parameters are estimated for a typical adult using topical ocular administration.</p><h4>References</h4><ol><li><p>Matera, MG, et al., &amp; Rossi, F (1998). Bioavailability of timolol and aceclidine after ocular instillation in the rabbit. <i>Research communications in molecular pathology and pharmacology</i> 100(1) 35â€“42. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9644717/&quot;>https://pubmed.ncbi.nlm.nih.gov/9644717</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S01EB58;
